title: Proceedings of the Psoriasis Combination and Rotation Therapy Conference. Deer Valley, Utah, Oct. 7-9, 1994.
authors.affiliation: Division of Dermatology, Baylor Psoriasis Center, Baylor University Medical Center, Dallas, TX, USA.
authors.forename: M A
authors.initials: MA
authors.lastname: Menter
authors.forename: J A
authors.initials: JA
authors.lastname: See
authors.forename: W J
authors.initials: WJ
authors.lastname: Amend
authors.forename: C N
authors.initials: CN
authors.lastname: Ellis
authors.forename: G G
authors.initials: GG
authors.lastname: Krueger
authors.forename: M
authors.initials: M
authors.lastname: Lebwohl
authors.forename: W L
authors.initials: WL
authors.lastname: Morison
authors.forename: J H
authors.initials: JH
authors.lastname: Prystowsky
authors.forename: H H
authors.initials: HH
authors.lastname: Roenigk
authors.forename: J L
authors.initials: JL
authors.lastname: Shupack
authors.forename: A K
authors.initials: AK
authors.lastname: Silverman
authors.forename: G D
authors.initials: GD
authors.lastname: Weinstein
authors.forename: D E
authors.initials: DE
authors.lastname: Yocum
authors.forename: M D
authors.initials: MD
authors.lastname: Zanolli
mesh_terms: D000279:Administration, Cutaneous; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004338:Drug Combinations; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011701:PUVA Therapy; D010778:Photochemotherapy; D011565:Psoriasis / Q000188:drug therapy*; D012176:Retinoids / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D003879:Dermatologic Agents; D004338:Drug Combinations; D007166:Immunosuppressive Agents; D012176:Retinoids; D016572:Cyclosporine; D008727:Methotrexate